Biosimilars Comparable to Aflibercept in Macular Disease ...Middle East

News by : (Medscape) -
Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity. Medscape Medical News

Hence then, the article about biosimilars comparable to aflibercept in macular disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosimilars Comparable to Aflibercept in Macular Disease )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار